VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hunter Vann who wrote (11130)	7/10/1998 10:55:00 AM
From: Frostman	Read Replies (2) of 23519

Hunter, I'm a KY boy too. Glad you vist the thread here. You said: <<Since the release of Viagra, out of these 40 or so men, we currently have 3 that are still taking Muse on a regular basis. As one might assume, the others have switched to the blue diamond shaped pill.>> I guess that means Muse has 7.5% of the ED business in your small but appropriate population. That would translate into some big numbers for Vivus nationally/globally. Vivus has always expected to simply have a small piece of a big pie with their current product, Muse. To me, you are describing what Edderd is talking about (the returning Muse patients) but from a different point of view. The types of ED all your patients have would be interesting to know, especially the 3 Muse clients. A difficult task at best beyond the obvious organic causes. I do know those 3 fellows would rather take a pill if it worked for them, I know I would. Frostman

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next